Aeglea BioTherapeutics | Results Presentation Deck | 13 slides

Aeglea BioTherapeutics · 2020-05
arc beats above · slides in the middle · loops below · scroll → 0 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

13
every slide · same image gating as the playbook
01
Slide 1
front_matter
02
front_matter
03
Includes a placeholder for a patient video and a callout regarding misdiagnosis.diagnose_problem
Open slide detailBeat · Problem
04
Uses a before-after framing to contrast standard of care failure with drug efficacy.diagnose_problem
Open slide detailBeat · Agitate
05
The slide uses a timeline-based process diagram to illustrate the study phases.present_framework
Open slide detailBeat · Solution
06
The slide is split into two main sections: Baseline Characteristics (left) and Safety Summary (right).analyze_data
Open slide detailBeat · Solution
07
The chart uses box plots to show distribution of plasma arginine (p[Arg]) over time compared to normal and target ranges.analyze_data
Open slide detailBeat · Solution
08
Includes before/after photos of the patient demonstrating improved mobility.illustrate_case
Open slide detailBeat · Solution
09
MCID = Minimal Clinically Important Difference. R indicates patients meeting or exceeding MCID.analyze_data
Open slide detailBeat · Solution
10
The 'R' icon denotes patients who achieved >=1 MCID improvement.analyze_data
Open slide detailBeat · Solution
11
The table uses color-coding to indicate responder status based on MCID thresholds.analyze_data
Open slide detailBeat · Solution
12
summarize
13
summarize